New method could help battle the worldwide danger of antibiotic resistance Kumar Jeetendra | July 4, 2020 Another strategy could help decrease anti-infection recommending by anticipating which medications could be viable in battling microscopic organisms in no time. Researchers at the University of Exeter have built up the technique, which permits clients to see whether a bacterium is probably going to react to anti-toxins. The examination is as of now in beginning …
Diphtheria is developing to get antibiotic-resistant safe and could prompt vaccine escape Kumar Jeetendra | March 8, 2021 Diphtheria – a comparatively easily-preventable infection – is evolving to become immune to a range of types of antibiotics and in the future could lead to vaccine escape, warn an international group of researchers in the UK and India. The researchers, led by scientists at the University of Cambridge, say that the impact of COVID-19 …
Deforestation in the Amazon builds variety of antibiotic-resistant bacteria Kumar Jeetendra | March 12, 2021 In Brazil, a study conducted by researchers affiliated with the University of São Paulo (USP) and collaborators showed that deforestation in the Amazon causes an increase in the diversity of antibiotic-resistant bacteria. An article on the study, published in Soil Biology and Biochemistry, compares the microorganisms that live in the land of indigenous forest with …
Antimicrobial Resistance ‘Arms Race’ Realizes Advancements as the Post-Antibiotic Era Ensues Kumar Jeetendra | August 25, 2021 BOULDER, CO – August 25 2021 – Antimicrobial Resistance (AMR) is “one of the greatest threats to society, human and animal health, and economic prosperity.” Those are the unequivocal words regarding the gravity of antimicrobial-resistant bacteria from the National Institute of Antimicrobial Resistance Research and Education. When one considers the significance of AMR—including antibiotic resistance—a …
Revolutionizing Infectious Disease: Dr. Paul’s Journey Kumar Jeetendra | May 12, 2025 In this captivating episode of our podcast series, we feature the world-renowned microbiologist, inventor, and thought leader in anti-infectives and infectious disease R&D, Dr. Maneesh Paul. Key Highlights: The story of Enmetazobactam – India’s first indigenously developed anti-infective and its journey from concept to global approvals (DCGI, USFDA, UKMHRA, EMA). Aspects of AMR, Planetary Health, …
Cipla Launches HUENA®, India’s First Non-Antibiotic UTI Drug Kumar Jeetendra | September 8, 2025 Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced the launch of Methenamine Hippurate, a non-antibiotic treatment for patients suffering from recurrent urinary tract infections (UTIs), under the brand name HUENA. This marks a significant step forward for Cipla in the fight against Anti-Microbial Resistance (AMR) and reinforces its commitment …
Infection control measures in Healthcare facilities Kumar Jeetendra | January 6, 2026 Infection-control infrastructure in India has seen recurring signals over the past few years that it needs strengthening. The Nipah virus alerts in Kerala spotlighted isolation, surveillance, and hygiene gaps, particularly in overstretched hospitals during 2024–2025. Nipah was just the headline, but beneath it lies a daily, quiet challenge: healthcare-associated infections i.e., HAIs, affecting 10-20% of Indian inpatients and are contributing …
Revolutionizing Diagnostics: How AST is Transforming Clinical Microbiology Kumar Jeetendra | March 18, 2026 The ability to give quick and accurate diagnoses is of paramount importance to the specialized fields of the ever-evolving world of healthcare. One of the most state-of-the-art innovations in healthcare and clinical microbiology laboratories is Antimicrobial Susceptibility Testing (AST), the newest technology for helping clinicians with the choice of treatment for an infectious disease. Providing …
